CS166011B2 - - Google Patents

Info

Publication number
CS166011B2
CS166011B2 CS4622A CS462270A CS166011B2 CS 166011 B2 CS166011 B2 CS 166011B2 CS 4622 A CS4622 A CS 4622A CS 462270 A CS462270 A CS 462270A CS 166011 B2 CS166011 B2 CS 166011B2
Authority
CS
Czechoslovakia
Application number
CS4622A
Other languages
Czech (cs)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of CS166011B2 publication Critical patent/CS166011B2/cs

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/34One oxygen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Polyurethanes Or Polyureas (AREA)
  • Processing And Handling Of Plastics And Other Materials For Molding In General (AREA)
CS4622A 1969-07-19 1970-07-02 CS166011B2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE1937629A DE1937629C3 (de) 1969-07-19 1969-07-19 Nitrofuryl-aminoalkoxy-pyriinidine

Publications (1)

Publication Number Publication Date
CS166011B2 true CS166011B2 (de) 1976-01-29

Family

ID=5740764

Family Applications (1)

Application Number Title Priority Date Filing Date
CS4622A CS166011B2 (de) 1969-07-19 1970-07-02

Country Status (19)

Country Link
US (1) US3707485A (de)
JP (1) JPS4911236B1 (de)
AT (1) AT294845B (de)
BE (1) BE753632A (de)
CA (1) CA929523A (de)
CH (1) CH540927A (de)
CS (1) CS166011B2 (de)
DE (1) DE1937629C3 (de)
DK (1) DK125097B (de)
ES (1) ES381433A1 (de)
FR (1) FR2059534B1 (de)
GB (1) GB1320548A (de)
IL (1) IL34882A (de)
NL (1) NL7010681A (de)
NO (1) NO127398B (de)
PL (1) PL70032B1 (de)
SE (1) SE367411B (de)
SU (1) SU471719A3 (de)
ZA (1) ZA704674B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2113529C3 (de) * 1971-03-17 1980-04-30 Schering Ag, 1000 Berlin Und 4619 Bergkamen 2-(5-Nitro-2-furyl)-5-(2-alkylaminoäthoxy)-pyrimidin-Verbindungen
JPS5131086U (de) * 1974-08-28 1976-03-06
US4648896A (en) * 1982-11-15 1987-03-10 Ciba-Geigy Corporation 2-aryl-4,6-dihalopyrimidines as antidote for protecting cultivated plants from phytotoxic damage caused by herbicides
NZ527046A (en) 2001-01-16 2005-06-24 Vascular Therapies Llc A flexible cylindrical matrix material, preferably collagen with an antiproliferative agent preferably rapamycin dispersed throughout for implantation to be in contact with a vascular structure

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1695849A1 (de) * 1967-06-23 1971-05-13 Schering Ag Verfahren zur Herstellung neuer Pyrimidinderivate

Also Published As

Publication number Publication date
ZA704674B (en) 1971-03-31
FR2059534A1 (de) 1971-06-04
DE1937629B2 (de) 1978-11-16
NO127398B (de) 1973-06-18
IL34882A (en) 1972-10-29
AT294845B (de) 1971-12-10
US3707485A (en) 1972-12-26
BE753632A (fr) 1971-01-18
PL70032B1 (de) 1973-12-31
DK125097B (da) 1972-12-27
GB1320548A (en) 1973-06-13
SE367411B (de) 1974-05-27
FR2059534B1 (de) 1974-03-22
ES381433A1 (es) 1972-12-01
CA929523A (en) 1973-07-03
NL7010681A (de) 1971-01-21
SU471719A3 (ru) 1975-05-25
DE1937629A1 (de) 1971-02-11
JPS4911236B1 (de) 1974-03-15
CH540927A (de) 1973-08-31
DE1937629C3 (de) 1979-07-26

Similar Documents

Publication Publication Date Title
AU2270770A (de)
AU465452B2 (de)
AU429630B2 (de)
AU450150B2 (de)
AU2355770A (de)
AU442375B2 (de)
AU427401B2 (de)
AU470301B1 (de)
FR2051491A1 (de)
AU442380B2 (de)
AU442463B2 (de)
AU428129B2 (de)
AU428131B2 (de)
AU425297B2 (de)
AU470661B1 (de)
AU438128B2 (de)
AT308690B (de)
AU417208B2 (de)
AU442322B2 (de)
AU442357B2 (de)
AU414607B2 (de)
AU428074B2 (de)
AU410358B2 (de)
AU442535B2 (de)
AU442538B2 (de)